Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
ITT
ITT
$18.3B
| $16.9M | 0.03% |
291,130
-64,973
| -18% | -$3.55M |
|
902
Moog Inc Class A
MOG.A
$12B
| $16.8M | 0.03% |
+193,589
| New | +$16.9M |
|
|
DVAX
903
DELISTED
Dynavax Technologies
DVAX
| $16.8M | 0.03% |
2,296,457
+1,681,527
| +273% | +$16.4M |
|
|
904
PUT
ConocoPhillips
COP
$160B
| $16.8M | 0.03% |
251,200
+153,700
| +158% | +$10.3M |
|
|
SAVE
905
DELISTED
Spirit Airlines, Inc.
SAVE
| $16.8M | 0.03% |
316,934
-301,574
| -49% | -$17.3M |
|
906
Planet Fitness
PLNT
$4.07B
| $16.7M | 0.03% |
243,214
+186,932
| +332% | +$11.3M |
|
907
AtriCure
ATRC
$2.51B
| $16.6M | 0.02% |
620,572
-257,002
| -29% | -$7.81M |
|
|
CERN
908
CALL
DELISTED
Cerner Corp
CERN
| $16.6M | 0.02% |
+290,000
| New | +$16.1M |
|
909
Provident Financial Services
PFS
$3.07B
| $16.5M | 0.02% |
636,708
+282,716
| +80% | +$7.41M |
|
910
Timken Company
TKR
$8.5B
| $16.5M | 0.02% |
377,618
-246,845
| -40% | -$10.5M |
|
911
iShares MSCI Mexico ETF
EWW
$1.79B
| $16.5M | 0.02% |
377,832
+138,431
| +58% | +$6.08M |
|
|
UNVR
912
DELISTED
Univar Solutions Inc.
UNVR
| $16.5M | 0.02% |
742,871
+251,248
| +51% | +$5.42M |
|
913
TherapeuticsMD
TXMD
$24M
| $16.4M | 0.02% |
67,547
+10,572
| +19% | +$2.8M |
|
914
Standard BioTools
LAB
$255M
| $16.4M | 0.02% |
1,234,402
+301,406
| +32% | +$3.18M |
|
|
ALXN
915
DELISTED
Alexion Pharmaceuticals
ALXN
| $16.4M | 0.02% |
121,327
-536,489
| -82% | -$66.7M |
|
916
GDS Holdings
GDS
$6.36B
| $16.4M | 0.02% |
459,282
+364,024
| +382% | +$11M |
|
917
Comfort Systems
FIX
$56.7B
| $16.4M | 0.02% |
312,793
-74,024
| -19% | -$3.69M |
|
918
Diamondrock Hospitality Co
DRH
$2.61B
| $16.4M | 0.02% |
1,510,872
+1,169,281
| +342% | +$12.1M |
|
919
Veeva Systems
VEEV
$40.4B
| $16.3M | 0.02% |
128,862
-773,154
| -86% | -$87.2M |
|
920
Navient
NAVI
$888M
| $16.3M | 0.02% |
1,410,402
+1,133,407
| +409% | +$13M |
|
921
Huntsman Corp
HUN
$1.68B
| $16.3M | 0.02% |
725,082
-603,382
| -45% | -$13.6M |
|
|
IBTX
922
DELISTED
Independent Bank Group, Inc.
IBTX
| $16.3M | 0.02% |
317,872
+168,561
| +113% | +$9.07M |
|
923
Celanese
CE
$4.97B
| $16.3M | 0.02% |
165,207
-483,451
| -75% | -$47.6M |
|
924
CALL
Becton Dickinson
BDX
$52B
| $16.3M | 0.02% |
66,830
+36,080
| +117% | +$8.53M |
|
925
KB Home
KBH
$3.41B
| $16.3M | 0.02% |
673,424
+340,220
| +102% | +$7.54M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.